ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag big pharma disease medicine

Two sets of identical twin children sitting
Identical Twins Carry Distinctive Epigenetic Marks: Study
Chloe Tenn | Sep 30, 2021 | 2 min read
Researchers found more than 800 sites in the genome where the twins bore the same chemical tags.
Career Supplement | Big Makeover for Big Pharma
Alison McCook | Jun 19, 2005 | 10 min read
Since the New York City life science technology-consulting firm Intrasphere Technologies opened an office in India, Samuel Goldman, cofounder and chief technology officer, says he works fairly bizarre hours, scheduling 6:00 A.M. meetings on a "regular basis."
Single Nucleotide Polymorphisms: Big Pharma Hedges its Bets
Eugene Russo | Jul 18, 1999 | 7 min read
SNP CENTRAL: A genetics researcher takes to the bench at the Wellcome Trust's Sanger Centre in Cambridge, England. The sequencing center and its London sponsor provided key leadership in the SNP Consortium, a public-private venture to find and map 300,000 single nucleotide polymorphisms. The Wellcome Trust helped entice 10 pharmaceutical firms to join the consortium by putting up $14 million of the project's estimated $45 million price tag. The Sanger Centre will provide much of the radiation h
Make Mine Rare
Megan Scudellari | Aug 1, 2011 | 7 min read
With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.
Matthew Disney
A Quest to Drug RNA
Ida Emilie Steinmark, PhD | Sep 8, 2023 | 5 min read
Matthew Disney’s idea of small molecules that target RNA once seemed fanciful. Now, even the pharma industry is pursuing it
Woman smiling at the camera working out on a blue yoga mat.
Keeping Older Muscles Strong
Hannah Thomasy, PhD, Drug Discovery News | Sep 5, 2023 | 5 min read
From stem cell-recruiting gels to hormone cycle restoration, Tracy Criswell has big ideas about how to combat age-related decline in muscle regeneration.
Novartis’s $9.7 Billion Purchase Includes Novel PCSK9 Inhibitor
Emily Makowski | Nov 25, 2019 | 2 min read
The pharmaceutical firm is buying The Medicines Company, which recently devoted its efforts into developing the cholesterol-lowering medication.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
The Scientist at Work in Big Pharma
Robert Calandra | Jan 26, 2003 | 5 min read
Ensconced in a darkened room at GlaxoSmithKline's suburban Philadelphia campus, Lara Kallander brings up an image of an X-ray crystallized compound on a wall screen. The image looks like a heap of brightly colored children's pickup-sticks arrayed at random angles. Kallander puts on a weighty pair of 3-D glasses. At first the left eye is annoyingly fuzzy, as if the lens is smudged. Then she hits a few keystrokes on the computer and suddenly the pickup sticks seem to pop off the screen. The lin
One hand holding the other, depicting pain in the joints
A Bacterial Culprit for Rheumatoid Arthritis
Hannah Thomasy, PhD, Drug Discovery News | Apr 27, 2023 | 4 min read
Scientists identified a species of Subdoligranulum that may drive disease.

Run a Search

ADVERTISEMENT